ORAMED PHARMACEUTICALS INC. Net Cash Provided by (Used in) Financing Activities in USD from Q4 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oramed Pharmaceuticals Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2010 to 2024.
  • Oramed Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$19M, a 882% decline year-over-year.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$52M, a 200% decline from 2023.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $52M, a 382% increase from 2022.
  • Oramed Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $10.8M, a 89.5% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

ORAMED PHARMACEUTICALS INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$19M -$21.4M -882% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-15
Q1 2023 $2.43M +$138K +6.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $2.29M -$26.7M -92.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $60.6M +$47.6M +366% Sep 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q1 2021 $29M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $13M +$13M Sep 1, 2020 Dec 31, 2020 10-QT 2022-03-30
Q4 2019 $13K* Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q4 2017 $5.16M +$4.84M +1513% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-14
Q4 2016 $320K +$156K +95.1% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-11
Q4 2015 $164K -$4.67M -96.6% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-11
Q4 2014 $4.83M Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-13
Q4 2012 $1.46M Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q4 2010 $300K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-12

ORAMED PHARMACEUTICALS INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$52M -$104M -200% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 $52M +$41.2M +382% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 $10.8M -$92.1M -89.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $103M +$79.1M +333% Sep 1, 2020 Aug 31, 2021 10-K 2023-03-06
2020 $23.8M Sep 1, 2019 Aug 31, 2020 10-K 2021-11-24
2018 $22.7M +$21.1M +1328% Sep 1, 2017 Aug 31, 2018 10-K 2019-11-27
2017 $1.59M -$10.5M -86.8% Sep 1, 2016 Aug 31, 2017 10-K 2019-11-27
2016 $12M +$2.32M +23.9% Sep 1, 2015 Aug 31, 2016 10-K 2018-11-28
2015 $9.72M -$6.92M -41.6% Sep 1, 2014 Aug 31, 2015 10-K 2017-11-29
2014 $16.6M +$10.8M +186% Sep 1, 2013 Aug 31, 2014 10-K 2016-11-25
2013 $5.82M +$2.34M +66.9% Sep 1, 2012 Aug 31, 2013 10-K 2015-11-25
2012 $3.49M -$205K -5.56% Sep 1, 2011 Aug 31, 2012 10-K 2014-11-14
2011 $3.69M Sep 1, 2010 Aug 31, 2011 10-K 2012-12-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.